Researcher
Wander Van Breedam
- Disciplines:Posttranslational modifications, Other biotechnology, bio-engineering and biosystem engineering not elsewhere classified, Medical biotechnology not elsewhere classified, Cell, tissue and organ engineering, Cellular therapy, Virology, Animal immunology
Affiliations
- Department of Biochemistry and microbiology (Department)
Member
From1 Oct 2014 → 31 Mar 2020 - Department of Translational Physiology, Infectiology and Public Health (Department)
Member
From1 Jan 2007 → 30 Sep 2014
Projects
1 - 1 of 1
- Characteristic glycosylation patterns displayed on porcine reproductive and respiratory syndrome virus (PRRSV) and PRRSV-infected cells and their role in interactions with sialic acid-binding immune system lectinsFrom1 Oct 2011 → 30 Sep 2014Funding: BOF - Other initiatives
Publications
1 - 10 of 36
- GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery(2023)
Authors: Loes van Schie, Wander Van Breedam, Charlotte Roels, Martin Frank, Ahmadreza Mehdipour, Bram Laukens, Wim Nerinckx, Francis Santens, Simon Devos, Iebe Rossey, et al.
- GlyConnect-Ugi : site-selective, multi-component glycoprotein conjugations through GlycoDelete expressed glycans(2022)
Authors: Karel Thooft, Wander Van Breedam, Francis Santens, Sandrine Vanmarcke, Simon Devos, Annemieke Madder
Pages: 464 - 471 - Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies (vol 181, pg 1004, 2020)(2020)
Authors: Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Gretel M. Torres, Nianshuang Wang, Wander Van Breedam, Loes van Schie, Markus Hoffmann, Stefan Pohlmann, Barney S. Graham, et al.
Pages: 1436 - 1441 - Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies(2020)
Authors: Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Gretel M. Torres, Nianshuang Wang, Wander Van Breedam, Loes van Schie, Markus Hoffmann, Stefan Poehlmann, Barney S. Graham, et al.
Pages: 1004 - 1015 - Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)(2017)
Authors: Jiexiong Xie, Isaura Christiaens, Bo Yang, Wander Van Breedam, Tingting Cui, Hans Nauwynck
Pages: 2030 - 2042 - Detection of total and PRRSV-specific antibodies in oral fluids collected with different rope types from PRRSV-vaccinated and experimentally infected pigs(2014)
Authors: Inge Decorte, Wander Van Breedam, Yves Van der Stede, Hans Nauwynck, Nick De Regge, Ann Brigitte Cay
- The intriguing game of porcine reproductive and respiratory syndrome virus with different macrophage subsets determines the virological and clinical outcome(2014)
Authors: Hans Nauwynck, Ilias Frydas, Ivan Trus, Isaura Christiaens, Caroline Bonckaert, Wander Van Breedam
Pages: 43 - 44 - Bitter-sweet symphony: glycanU+2013lectin interactions in virus biology(2014)
Authors: Wander Van Breedam, Stefan Pöhlmann, Herman Favoreel, Raoul de Groot, Hans Nauwynck
Pages: 598 - 632 - Changing receptor use of PRRSV leads to different virological, immunological and clinical outcome: impact on diagnosis and control(2014)
Authors: Hans Nauwynck, Ilias Frydas, Isaura Christiaens, Wander Van Breedam, Caroline Bonckaert, Ivan Trus
Pages: 23 - 26 - Porcine, murine and human sialoadhesin (Sn/Siglec-1/CD169): portals for porcine reproductive and respiratory syndrome virus entry into target cells(2013)
Authors: Wander Van Breedam, Mieke Verbeeck, Isaura Christiaens, Hanne Van Gorp, Hans Nauwynck
Pages: 1955 - 1960
Patents
1 - 7 of 7
- GLYCOSYLATED SINGLE CHAIN IMMUNOGLOBULIN DOMAINS (Inventor)
- Means and methods for the production of glycoproteins comprising homogeneous galactosylated carbohydrates (Inventor)
- Genetically engineered eukaryotic cells producing sialylated glycoproteins (Inventor)
- Glycosylation of variable immunoglobulin domains (Inventor)
- Means and methods for the production of glycoproteins comprising homogeneous galactosylated carbohydrates (Inventor)
- Genetically engineered eukaryotic cells producing sialylated glycoproteins (Inventor)
- Glycosylation of variable immunoglobulin domains (Inventor)